WG
RMD icon

Winton Group’s ResMed RMD Stock Holding History

Winton Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
+7,900
New +$1.64M 0.05% 373
2022
Q4 		– Sell
-2,719
Closed -$594K – 1022
2022
Q3 		$594K Buy
+2,719
New +$619K 0.04% 588
2021
Q4 		– Sell
-3,336
Closed -$879K – 1332
2021
Q3 		$879K Buy
+3,336
New +$912K 0.05% 569
2020
Q2 		– Sell
-1,985
Closed -$292K – 1568
2020
Q1 		$292K Sell
1,985
-69,415
-97% -$11.1M 0.01% 1176
2019
Q4 		$11.1M Sell
71,400
-8,256
-10% -$1.19M 0.16% 201
2019
Q3 		$10.8M Buy
79,656
+63,070
+380% +$8.26M 0.13% 198
2019
Q2 		$2.02M Buy
16,586
+13,184
+388% +$1.46M 0.04% 287
2019
Q1 		$354K Sell
3,402
-117,352
-97% -$12.1M 0.01% 733
2018
Q4 		$13.8M Buy
120,754
+106,967
+776% +$11.5M 0.3% 127
2018
Q3 		$1.59M Buy
13,787
+7
+0.1% +$767 0.03% 328
2018
Q2 		$1.43M Sell
13,780
-59,288
-81% -$6M 0.04% 366
2018
Q1 		$7.2M Sell
73,068
-1,110
-1% -$105K 0.2% 125
2017
Q4 		$6.28M Buy
74,178
+66,102
+818% +$5.46M 0.18% 160
2017
Q3 		$622K Buy
8,076
+640
+9% +$49K 0.02% 502
2017
Q2 		$579K Buy
+7,436
New +$532K 0.02% 479
2016
Q4 		– Sell
-197,404
Closed -$12.8M – 484
2016
Q3 		$12.8M Buy
197,404
+98,696
+100% +$6.57M 0.22% 162
2016
Q2 		$6.24M Buy
98,708
+75,978
+334% +$4.48M 0.1% 225
2016
Q1 		$1.31M Sell
22,730
-414,893
-95% -$23.5M 0.01% 281
2015
Q4 		$23.5M Buy
437,623
+52,824
+14% +$2.98M 0.21% 183
2015
Q3 		$19.6M Sell
384,799
-96,047
-20% -$5.17M 0.16% 233
2015
Q2 		$27.1M Sell
480,846
-146,275
-23% -$9.23M 0.25% 156
2015
Q1 		$45M Buy
627,121
+553,651
+754% +$36M 0.36% 97
2014
Q4 		$4.12M Sell
73,470
-83,689
-53% -$4.37M 0.05% 339
2014
Q3 		$7.74M Sell
157,159
-322,485
-67% -$16.4M 0.06% 344
2014
Q2 		$24.3M Buy
+479,644
New +$23.8M 0.17% 244

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Winton Group's RMD Position: Q2 2026 in Review

Winton Group opened a new position in ResMed (RMD) in Q2 2026: 7,900 shares worth $1.54M. The stake represents 0.05% of the portfolio and ranks #373 among its holdings. This is a return to the name: Winton Group previously reported a position in RMD as recently as Q3 2022.

Winton Group first reported a position in RMD in Q2 2014 and has held it in 25 quarters since. The position peaked at $45M in Q1 2015. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Winton Group held 7,900 shares of ResMed worth $1.54M as of Q2 2026.
  • ResMed was a new Winton Group position in Q2 2026.
  • ResMed made up 0.05% of Winton Group's portfolio in Q2 2026, its #373 holding.
  • Winton Group first reported a position in ResMed in Q2 2014 and has held it in 25 quarters since.
  • Winton Group's ResMed position peaked at $45M in Q1 2015.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.